Redhawk Wealth Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Redhawk Wealth Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-119,400	Closed	-$29.5K	–	446
2026 Q1	$29.5K	Buy	+119,400	New	+$47.5K	﹤0.01%	387

Redhawk Wealth Advisors's SGMO Position: Q2 2026 in Review

Redhawk Wealth Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 119,400 shares — an estimated $29.5K sold.

Redhawk Wealth Advisors first reported a position in SGMO in Q1 2026 and held it in 1 quarter. The position peaked at $29.5K in Q1 2026. 0 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Redhawk Wealth Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Redhawk Wealth Advisors sold 119,400 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $29.5K.
Redhawk Wealth Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and held it in 1 quarter.
Redhawk Wealth Advisors's SANGAMO THERAPEUTICS INC position peaked at $29.5K in Q1 2026.
0 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.